US 12,731,684 B2
Method and system for generating a software-implemented module for determining an analyte value, computer program product, and method and system for determining an analyte value
Larissa Becka, Munich (DE); Alexander Buesser, Zürich (CH); Tony Huschto, Speyer (DE); Yannick Klopfenstein, Neuchatel (CH); David Mesterhazy, Nuremberg (DE); Mike Rinderknecht, Zürich (CH); and Christian Ringemann, Mannheim (DE)
Assigned to Roche Diabetes Care, Inc., Indianapolis, IN (US)
Filed by Roche Diabetes Care, Inc., Indianapolis, IN (US)
Filed on Nov. 18, 2022, as Appl. No. 18/057,060.
Application 18/057,060 is a continuation of application No. PCT/EP2021/063009, filed on May 17, 2021.
Claims priority of application No. 20175348 (EP), filed on May 19, 2020.
Prior Publication US 2023/0092186 A1, Mar. 23, 2023
Int. Cl. G16H 50/20 (2018.01); G06N 20/00 (2019.01); G16H 10/20 (2018.01); G16H 40/63 (2018.01)
CPC G16H 40/63 (2018.01) [G06N 20/00 (2019.01)] 15 Claims
OG exemplary drawing
 
1. A method for generating a software-implemented module for use in a glucose monitoring system to determine a glucose value in a body fluid, the method comprising:
(A) providing a first set of input data indicative of first values measured for a first input parameter and a second input parameter, wherein the first input parameter and/or the second input parameter is selected from the group of input parameters consisting of: glucose level measured by a continuous glucose sensor, insulin bolus, carbohydrate intake, active bolus insulin, active basal insulin, activity level, insulin sensitivity factor, carbohydrate ratio, stress level, and glycemic index of carbohydrates;
(B) providing a second set of input data indicative of second values for the first and second input parameters, the second values comprising:
(i) an augmented value for the first parameter, the augmented value being different from the first value measured for the first input parameter, and
(ii) the first value for the second input parameter;
(C) determining first analyte data indicative of a first set of glucose values in a body fluid by processing the first set of input data from Step (A) by a physiological model;
(D) determining second analyte data indicative of a second set of glucose values by processing the second set of input data from Step (B) by the physiological model;
(E) determining a set of training data from both the first analyte data and the second analyte data;
(F) determining a set of test data different from the set of training data;
(G) providing a software-implemented machine learning model configured to determine a glucose value in a body fluid of a patient;
(H) training the software-implemented machine learning model by the set of training data;
(I) testing the software-implemented machine learning model by the set of test data;
(J) deploying the generated software implemented module for use in the glucose monitoring system to analyze a present input data and determine an analyte value, wherein the analyte value is a present analyte value and/or a future analyte value.